Kelly Anderson - 30 Jun 2021 Form 4 Insider Report for Guardion Health Sciences, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 30 Jun 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jul 2021, 08:30:45 UTC
Next SEC filing: 21 Jan 2022
Source filing: View source filing
Reporting owner signature: /s/ Bret Scholtes as Attorney-In-Fact for Kelly Anderson

Key filing fact

Kelly Anderson filed Form 4 for Guardion Health Sciences, Inc. on 02 Jul 2021.

Key facts

This page summarizes Kelly Anderson's Form 4 filing for Guardion Health Sciences, Inc..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 02 Jul 2021, 08:30.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GHSI transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +16,667
Change %
Price: $0.000000
Shares after: 16,667
Date: 30 Jun 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 16,667
Exercise price: $1.76
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option shall vest and become exercisable in eight equal installments on the last day of each of the subsequent eight calendar quarter-end dates following the date of grant (the first of such dates being September 30, 2021).

SEC remarks

Exhibit List: Exhibit 24 - Power of Attorney